Template:Pyrazinamide: Difference between revisions

Latest revision as of 02:53, 4 January 2014

Pyrazinamide
PYRAZINAMIDE^® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied

@@ Line 1: / Line 1: @@
 {| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
-| style="padding: 0 5px; font-size: 100%; background:#696969" align=center | <span style="color:WHITE;"> '''[[Pyrazinamide|Pyrazinamide]]'''</span>
+! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Pyrazinamide|{{fontcolor|#6C7B8B|Pyrazinamide}}]]'''''
 |-
-! style="padding: 0 5px; font-size: 85%; background:WHITE" align=left | FDA Package Insert (MIKART<sup>®</sup>)
+! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | PYRAZINAMIDE<sup>®</sup> FDA Package Insert
 |-
 ! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Pyrazinamide description|Description]]